Form 4 holding
Director
MoonLake Immunotherapeutics
- Security class
- Class A ordinary shares, par value $0.0001 per share
- Shares / value
- 171,980
- Estimated value
- $9,238,766
- Report date
- 04 Oct 2024
- Price
- $53.72
- Ownership
- Direct